Denial Reduction: From 10%+ to Under 0.5%
MoodRx reduced internal claim denials from more than 10% to below 0.5% over about a year. Here is the operating process behind the improvement.
Tag: Case Study
1post tagged “Case Study”.
1post tagged “Case Study”.
MoodRx reduced internal claim denials from more than 10% to below 0.5% over about a year. Here is the operating process behind the improvement.